XT
VOR icon

XTX Topco’s Vor Biopharma VOR Stock Holding History

XTX Topco’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,542
Closed -$229K – 4438
2025
Q4 		$229K Buy
+17,542
New +$327K 0.01% 2292
2025
Q3 		– Sell
-2,047
Closed -$66.3K – 3338
2025
Q2 		$66.3K Buy
+2,047
New +$18.1K ﹤0.01% 1966
2025
Q1 		– Sell
-3,589
Closed -$79.7K – 3174
2024
Q4 		$79.7K Buy
+3,589
New +$59.5K 0.01% 1814
2024
Q2 		– Sell
-932
Closed -$44.2K – 2509
2024
Q1 		$44.2K Buy
+932
New +$40.9K 0.01% 1487

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco's VOR Position: Q1 2026 in Review

XTX Topco sold out of Vor Biopharma (VOR) in Q1 2026, closing a stake of 17,542 shares — an estimated $229K sold.

XTX Topco first reported a position in VOR in Q1 2024 and held it in 4 quarters. The position peaked at $229K in Q4 2025. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • XTX Topco reported no remaining Vor Biopharma position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 17,542 Vor Biopharma shares in Q1 2026, an estimated $229K.
  • XTX Topco first reported a position in Vor Biopharma in Q1 2024 and held it in 4 quarters.
  • XTX Topco's Vor Biopharma position peaked at $229K in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.